Millennium Petitions FDA to Hold Off on Approvals of Generic Velcade

Drug Industry Daily
A A
Takeda subsidiary Millennium Pharmaceuticals called on the FDA to withhold approval for generic versions of its drug Velcade (bortezomib) until at least next February, when a relevant exclusivity period expires.

To View This Article:

Login

Subscribe To Drug Industry Daily